Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Valicenti Advisory Services Inc.

Valicenti Advisory Services Inc. lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 27,844 shares of the medical equipment provider’s stock after selling 2,435 shares during the period. Intuitive Surgical makes up approximately 3.5% of Valicenti Advisory Services Inc.’s holdings, making the stock its 6th largest position. Valicenti Advisory Services Inc.’s holdings in Intuitive Surgical were worth $13,790,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in ISRG. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC raised its stake in Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after purchasing an additional 243,802 shares during the last quarter. Fisher Asset Management LLC raised its position in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after buying an additional 86,488 shares during the last quarter. Norges Bank bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $2,401,493,000. Finally, Invesco Ltd. raised its stake in shares of Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock valued at $2,165,184,000 after purchasing an additional 295,025 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.6%

ISRG opened at $523.08 on Wednesday. The stock has a market capitalization of $187.48 billion, a PE ratio of 76.70, a PEG ratio of 5.46 and a beta of 1.67. Intuitive Surgical, Inc. has a 1-year low of $413.82 and a 1-year high of $616.00. The firm has a 50-day moving average price of $529.22 and a two-hundred day moving average price of $536.97.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter last year, the business posted $1.50 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In related news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now directly owns 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now owns 2,245 shares of the company’s stock, valued at approximately $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 4,998 shares of company stock valued at $2,611,577. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. Citigroup restated a “buy” rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Robert W. Baird dropped their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Finally, BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.